The addition of blinatumomab (Blincyto) to consolidation chemotherapy conferred a big general survival (OS) profit in contrast with consolidation chemotherapy alone in sufferers...
Ipsen secures ex-U.S. regulatory and business rights to tovorafenib for most typical childhood mind tumor, pediatric low-grade glioma (pLGG), and any future indications
OJEMDA™...